CIENCIASMEDICASNEWS: Medical News | Medical Articles: AF4-MALS-DLS for lipid nanoparticle characterization

martes, 1 de octubre de 2019

Medical News | Medical Articles: AF4-MALS-DLS for lipid nanoparticle characterization

	October 1, 2019
	Nanomedicine
	The latest nanomedicine news from News Medical

AF4-MALS-DLS for lipid nanoparticle characterization

Lipid nanoparticle nanoDDS used to deliver proteins, DNA\RNA or small-molecule drugs are characterized by light scattering with field-flow fractionation to provide detailed distributions of size, structure and concentration. AF4-MALS-DLS is also used to study encapsulation efficiency and payload transfer.

Download the Whitepaper

			Plasmonics in Biology and Nanomedicine Plasma is one of the fundamental states of matter that is generated when a neutral gas is heated or subjected to a strong electromagnetic field, both of which can result in the breaking of bonds and the stripping of electrons from atomic nuclei.

			Researchers develop new anti-cancer nanomedicine for targeted chemotherapy Researchers at the University of Helsinki in collaboration with researchers from åbo Akademi University, Finland and Huazhong University of Science and Technology, China have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

	Advancing towards 100% effective herpes vaccine A new vaccine precursor has been reported to provide complete protection (sterilizing immunity) in animal trials involving a high dose of the HSV-2 virus. The new formulation is based on a modification of the viral RNA which is encapsulated within nanoparticles.

	Nanoparticles moving through airway mucus may predict severity of COPD In a proof-of-concept experiment, researchers from Johns Hopkins Medicine say they have successfully used microscopic man-made particles to predict the severity of patients' chronic obstructive pulmonary disease by measuring how quickly the particles move through mucus samples.

	Novel nanogels could precisely deliver therapeutic treatments to cancer patients Researchers at The University of Texas at Austin have developed new guidelines for fabricating nanoscale gel materials, or nanogels, that can deliver numerous therapeutic treatments to treat cancer in a precise manner.

	Researchers study biological risk potential of nanoparticles Nanoparticles are smaller than five nanometres - a nanometre being one millionth of a millimetre - which corresponds approximately to the size of macromolecules. Such tiny particles are very easily absorbed in body cells.

	Nanoparticles activated by X rays used to target deep tumours A team of researchers from University of Texas at Arlington, University of Rhode Island and Brown University have collaborated to come up with use of nanoparticles in targeted therapy for deep seated cancers.